Jan 1, 1977

Interactions between cardioactive drugs and antidepressants

European Journal of Clinical Pharmacology
G Cocco, C Agué

Abstract

The most important cardiovascular interactions between cardioactive drugs and monoamino-oxidase inhibitors or tricyclic antidepressants are reviewed. Post-ganglion blocking agents (e.g., guanethidine), clonidine, reserpine, and alpha-methyl-dopa should not be used in patients needing antide-present therapy. For hypertension, diuretics, beta-blokkers, and vasodilators should be used. In patients with cardiac disease negative interactions between membrane-stabilizing antiarrhythmic agents and tricyclic antidepressants may be observed. Caution is recommended when using both drugs. On the other hand, the use of digitalis is relatively free of negative interactions. Some of the mechanisms possibly involved are discussed. The practical implications of such effects are presented and some clinically useful guidelines are suggested.

  • References19
  • Citations3

References

Mentioned in this Paper

Cardiac Depressants
RIMA (Reversible Inhibitor of Monoamine Oxidase A)
Antihypertensive Agents
Drug Interactions
Heart
Hemodynamics
Thymoleptics
Heart Diseases
Electrocardiographic Recorders
Tricyclic Antidepressive Agents

About this Paper

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.